Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients

Metabolism: Clinical and Experimental

Volumn 60, Issue 12, 2011, Pages 1775-1780

  Baudrand, René ^a   Domínguez, José Miguel ^a   Carvajal, Cristian A ^a   Riquelme, Arnoldo ^a   Campino, Carmen ^a   MacChiavello, Stefano ^a   Bozinovic, Milan ^a   Morales, Mauricio ^a   Pizarro, Margarita ^a   Solis, Nancy ^a   Escalona, Alex ^a   Boza, Camilo ^a   Arrese, Marco ^a   Fardella, Carlos E ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOSE; HYDROCORTISONE; INSULIN; RNA 18S; STEROID 5ALPHA REDUCTASE; STEROID 5BETA REDUCTASE;

ADULT; ANTHROPOMETRY; ARTICLE; BIOCHEMISTRY; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INTRAABDOMINAL FAT; LIVER LEVEL; MALE; MORBID OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ADIPONECTIN; ADULT; AGED; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTENONE 5 ALPHA-REDUCTASE; CUSHING SYNDROME; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYDROCORTISONE; HYPERINSULINISM; INSULIN; INTRA-ABDOMINAL FAT; LIPIDS; LIVER; MALE; MIDDLE AGED; OBESITY, MORBID; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 81155133819     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.05.001     Document Type: Article

References (32)

1. K. Obunai, S. Jani, and G.D. Dangas Cardiovascular morbidity and mortality of the metabolic syndrome Med Clin North Am 91 2007 1169 1184 (Pubitemid 350010914)
2. P. Kokkoris, and F.X. Pi-Sunyer Obesity and endocrine disease Endocrinol Metab Clin North Am 32 2003 895 914 (Pubitemid 38029986)
3. A.R. Glass, K.D. Burman, and W.T. Dahms Endocrine function in human obesity Metab Clin Exp 30 1981 89 104 (Pubitemid 11104924)
4. I.J. Bujalska, S. Kumar, and P.M. Stewart Does central obesity reflect "Cushing's disease of the omentum"? Lancet 26 1997 1210 1213 (Pubitemid 27190044)
5. B.R. Walker, and R. Andrew Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease Ann N Y Acad Sci 1083 2006 165 184 (Pubitemid 44955472)
6. R. Baudrand, C.A. Carvajal, and A. Riquelme Overexpression of 11beta-hydroxysteroid dehydrogenase 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients Obes Surg 20 2010 77 83
7. J.W. Tomlinson, E.A. Walker, and I.J. Bujalska 11beta-Hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response Endocr Rev 25 2004 831 866 (Pubitemid 39366049)
8. L. Alberti, A. Girola, and L. Gilardini Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects Int J Obes (Lond) 31 2007 1826 1831 (Pubitemid 350174630)
9. M.S. Cooper, and P.M. Stewart 11beta-Hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation J Clin Endocrinol Metab 94 2009 4645 4654
10. T.C. Friedman, G. Mastorakos, and T.D. Newman Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM Endocr J 4 1996 645 655 (Pubitemid 126447899)
11. C. Campino, C.A. Carvajal, and J. Cornejo 11beta-Hydroxysteroid dehydrogenase type-2 and type-1 (11beta-HSD2 and 11beta-HSD1) and 5beta-reductase activities in the pathogenesis of essential hypertension Endocrine 37 2010 106 114
12. D.W. Russell, and J.D. Wilson Steroid 5 alpha-reductase: two genes/two enzymes Annu Rev Biochem 63 1994 25 61
13. D.E. Livingstone, K.J. McInnes, and B.R. Walker Increased A-ring reduction of glucocorticoids in obese Zucker rats: effects of insulin sensitization Obes Res 13 2005 1523 1526
14. A.M. Acosta, M. Escalona, and A. Maiz Determination of the insulin resistance index by the homeostasis model assessment in a population of metropolitan region in Chile Rev Med Chil 130 2002 1227 1231
15. R. Basu, A. Basu, and M. Grudzien Liver is the site of splanchnic cortisol production in obese nondiabetic humans Diabetes 58 2009 39 45
16. R. Basu, R.J. Singh, and A. Basu Splanchnic cortisol production occurs in humans: evidence for conversion of cortisone to cortisol via the 11-beta hydroxysteroid dehydrogenase (11beta-hsd) type 1 pathway Diabetes 53 2004 2051 2059 (Pubitemid 38970754)
17. J.W. Tomlinson, J. Finney, and C. Gay Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity Diabetes 57 2008 2652 2660
18. V. Vicennati, F. Pasqui, and C. Cavazza Stress-related development of obesity and cortisol in women Obesity (Silver Spring) 17 2009 1678 1683
19. R.A. Rizza, L.J. Mandarino, and J.E. Gerich Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action J Clin Endocrinol Metab 54 1982 131 138 (Pubitemid 13242146)
20. M.F. Nielsen, A. Caumo, and V. Chandramouli Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects Am J Physiol Endocrinol Metab 286 2004 E102 E110
21. A. Vegiopoulos, and S. Herzig Glucocorticoids, metabolism and metabolic diseases Mol Cell Endocrinol 15 2007 43 61 (Pubitemid 47259280)
22. D.H. Van Raalte, D.M. Ouwens, and M. Diamant Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39 2009 81 93
23. A.G. Rockall, S.A. Sohaib, and D. Evans Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography Eur J Endocrinol 149 2003 543 548 (Pubitemid 38054698)
24. S. Konopelska, T. Kienitz, and B. Hughes Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis Clin Endocrinol (Oxf) 70 2009 554 560
25. C. Boza, A. Riquelme, and L. Ibanez Predictors of nonalcoholic steatohepatitis (NASH) in obese patients undergoing gastric bypass Obes Surg 15 2005 1148 1153 (Pubitemid 41390213)
26. H. Masuzaki, J. Paterson, and H. Shinyama A transgenic model of visceral obesity and the metabolic syndrome Science 7 2001 2166 2170 (Pubitemid 33150673)
27. N.M. Morton, J.M. Paterson, and H. Masuzaki Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice Diabetes 53 2004 931 938 (Pubitemid 38436604)
28. P.U. Feig, S. Shah, and A. Hermanowski Vosatka Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome Diabetes Obes Metab 13 6 2011 498 504
29. M. Berthiaume, M. Laplante, and W.T. Festuccia Preliminary report: pharmacologic 11beta-hydroxysteroid dehydrogenase type 1 inhibition increases hepatic fat oxidation in vivo and expression of related genes in rats fed an obesogenic diet Metabolism 59 2010 114 117
30. G. Valsamakis, A. Anwar, and J.W. Tomlinson 11beta-Hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus J Clin Endocrinol Metab 89 2004 4755 4761 (Pubitemid 39244498)
31. B.R. Walker Cortisol-cause and cure for metabolic syndrome? Diabet Med 23 2006 1281 1288
32. I. Bengtsson, L. Lissner, and T. Liung The cortisol awakening response and the metabolic syndrome in a population-based sample of middle-aged men and women Metabolism 59 2010 1012 1019